Tag: TCT 2019
Two further studies support three-month DAPT following PCI
Further evidence for a shorter duration of dual antiplatelet therapy (DAPT) in patients implante...
Patients with angiographically-intermediate coronary lesions
Using optical coherence tomography (OCT)-to guide percutaneous coronary intervention (PCI) is as...
BIBA Briefings: Henry V can inspire us to develop innovative techniques for reducing radiation exposure
During a session on radiation protection technologies at the 2019 Transcatheter Cardiovascular T...
Abiomed announces PROTECT III clinical data for protected PCI with Impella
Abiomed has announced the results of PROTECT III, an ongoing, prospective, single-arm US Food an...
TCT 2019: Resolute Onyx noninferior to BioFreedom in high bleeding risk patients treated with one-month DAPT
ONYX ONE, the first randomised trial to compare a durable polymer drug-eluting stent to a polyme...
TCT 2019: TAVI has sustained health status benefits over surgery for low-risk patients at one year, with similar five-year outcomes for intermediate-risk patients, unless via a transthoracic route
A subanalysis of PARTNER 3 quality of life data demonstrated a modest, but significant, improvem...
TCT 2019: Benefits of complete revascularisation continue to accumulate over the long term
A timing substudy of the COMPLETE trial has found that, compared with culprit-lesion only percut...
TCT 2019: COAPT finds MitraClip safety and efficacy is maintained at three years, and is cost-effective
The MitraClip device (Abbott) continues to demonstrate safety and efficacy at three years in pat...
TCT 2019: Acurate neo does not meet non-inferiority compared to Sapien 3
The first randomised trial to compare the safety and efficacy of the Acurate neo transcatheter h...
TCT 2019: Safety and efficacy of Portico valve noninferior to FDA-approved TAVI systems
The Portico IDE study has found that 30-day safety and one-year effectiveness outcomes of a nove...
TCT 2019: Aspirin withdrawal after three months of dual antiplatelet therapy reduces bleeding without an increase in ischaemic events among high-risk patients following PCI
Data from the TWILIGHT study demonstrate that, compared to ticagrelor plus aspirin, ticagrelor m...
Boston Scientific announces schedule of presentations at TCT 2019
Boston Scientific has announced the key data that will be presented at the Transcatheter Cardiov...
Corindus showcasing CorPath GRX system at TCT 2019
Corindus Is to showcase the CorPath GRX system at the Transcatheter Cardiovascular Therapeutics ...
